zoledronic acid has been researched along with Muscular Dystrophy, Duchenne in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briody, J; Emmanuel, J; Gryllakis, J; Heather, N; Jefferies, C; Lee, KJ; Lim, A; Munns, CF; Pitkin, J; Siafarikas, A; Simm, PJ; Wang, X; Zacharin, M | 1 |
| de Valle, K; Lim, A; Pitkin, J; Ryan, MM; Simm, PJ; Zacharin, M | 1 |
| Bloetzer, C; Buclin, T; García Segarra, N; Ivanyuk, A; Jacquier, D; Klein, A; Newman, CJ | 1 |
| Dharmaraj, P; Lemon, J; Spinty, S; Turner, L | 1 |
| Bell, JM; Beringer, T; Blackwood, B; Elliott, M; Hamilton, A; Quinlivan, R; Shields, MD; Tirupathi, S; Watters, J | 1 |
1 review(s) available for zoledronic acid and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Calcium; Child; Child, Preschool; Diphosphonates; Humans; Imidazoles; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Risedronic Acid; Spinal Fractures; Vibration; Vitamin D; Weight-Bearing; Zoledronic Acid | 2017 |
1 trial(s) available for zoledronic acid and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Child; Humans; Lumbar Vertebrae; Male; Muscular Dystrophy, Duchenne; Treatment Outcome; Vitamin D; Zoledronic Acid | 2021 |
3 other study(ies) available for zoledronic acid and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Therapeutic Options to Improve Bone Health Outcomes in Duchenne Muscular Dystrophy: Zoledronic Acid and Pubertal Induction.
Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Child; Humans; Male; Muscular Dystrophy, Duchenne; Zoledronic Acid | 2017 |
Myoglobinuria in two patients with Duchenne muscular dystrophy after treatment with zoledronate: a case-report and call for caution.
Topics: Adolescent; Bone Density Conservation Agents; Humans; Male; Muscular Dystrophy, Duchenne; Myoglobinuria; Zoledronic Acid | 2018 |
Rhabdomyolysis and myoglobinuria following bisphosphonate infusion in patients with Duchenne muscular dystrophy.
Topics: Diphosphonates; Humans; Muscular Dystrophy, Duchenne; Myoglobinuria; Rhabdomyolysis; Zoledronic Acid | 2019 |